US Bancorp DE raised its position in Amentum Holdings, Inc. (NYSE:AMTM - Free Report) by 2,872.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,942 shares of the company's stock after buying an additional 27,002 shares during the period. US Bancorp DE's holdings in Amentum were worth $588,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AMTM. Wilmington Savings Fund Society FSB bought a new position in shares of Amentum in the third quarter worth about $790,000. Wharton Business Group LLC bought a new position in shares of Amentum in the third quarter worth about $2,106,000. JPMorgan Chase & Co. bought a new stake in shares of Amentum during the third quarter worth approximately $8,739,000. Peak Asset Management LLC bought a new stake in shares of Amentum during the third quarter worth approximately $774,000. Finally, Foundations Investment Advisors LLC bought a new stake in shares of Amentum during the fourth quarter worth approximately $409,000. 39.93% of the stock is currently owned by institutional investors and hedge funds.
Amentum Price Performance
Shares of AMTM opened at $17.06 on Wednesday. Amentum Holdings, Inc. has a fifty-two week low of $16.95 and a fifty-two week high of $34.47. The company has a 50-day moving average of $21.08. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.59 and a current ratio of 1.59.
Amentum (NYSE:AMTM - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.06. As a group, equities research analysts anticipate that Amentum Holdings, Inc. will post 2.1 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, insider Steven J. Demetriou purchased 100,000 shares of Amentum stock in a transaction dated Wednesday, February 12th. The shares were bought at an average cost of $20.81 per share, for a total transaction of $2,081,000.00. Following the purchase, the insider now owns 620,893 shares in the company, valued at approximately $12,920,783.33. This trade represents a 19.20 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Barbara Loughran purchased 4,600 shares of Amentum stock in a transaction dated Tuesday, February 18th. The stock was bought at an average price of $21.23 per share, for a total transaction of $97,658.00. Following the completion of the purchase, the director now owns 4,600 shares in the company, valued at $97,658. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 18.67% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Raymond James assumed coverage on shares of Amentum in a research note on Thursday, November 21st. They set an "outperform" rating and a $30.00 price target for the company. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $24.00 target price on shares of Amentum in a research note on Thursday, February 6th. Finally, Cantor Fitzgerald raised shares of Amentum to a "hold" rating in a research note on Tuesday, February 25th.
Check Out Our Latest Analysis on AMTM
Amentum Company Profile
(
Free Report)
Amentum Holdings, Inc provides engineering and technology solutions to address challenges in science, security, and sustainability. It serves various markets, such as energy and environment, space, intelligence, defense, civilian, commercial, and international markets. The company was incorporated in 2010 and is headquatered in Chantilly, Virginia.
Featured Stories
Want to see what other hedge funds are holding AMTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amentum Holdings, Inc. (NYSE:AMTM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amentum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amentum wasn't on the list.
While Amentum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.